Long-term results after simultaneous carotid and coronary revascularisation.


Journal

Asian cardiovascular & thoracic annals
ISSN: 1816-5370
Titre abrégé: Asian Cardiovasc Thorac Ann
Pays: England
ID NLM: 9503417

Informations de publication

Date de publication:
Nov 2022
Historique:
pubmed: 7 9 2022
medline: 20 10 2022
entrez: 6 9 2022
Statut: ppublish

Résumé

The revascularisation strategy for concomitant carotid and coronary disease is unknown. Simultaneous or stage coronary artery stenting and carotid endarterectomy are the most common revascularisation approach in the CABG population. This study aimed to evaluate long-term results after simultaneous carotid artery stenting or carotid endarterectomy in patients who underwent coronary artery bypass surgery. This is a prospective cohort non-randomised single-institution study. During the period from 2012 to 2015, sixty consecutive patients (65.9 ± 7.41 mean) underwent simultaneous carotid artery stenting and coronary artery bypass surgery ( In-hospital mortality was insignificantly higher in the carotid endarterectomy, and coronary artery bypass surgery group (6.6% vs. 0%), the rate of stroke and myocardial infarction was similar (13.3% and 0% in the carotid endarterectomy and coronary artery bypass surgery group vs. 6.6% and 3.3% in the carotid artery stenting and coronary artery bypass surgery group, respectively). The intensive care unit readmission was significantly higher in the surgical revascularisation approach; it was an independent predictor of hospital mortality. The overall mortality during the follow-up period was 14.28% in both groups. Freedom of the composite adverse outcomes (stroke, myocardial infarction, and death) was 78.55%. Comparing two revascularisation strategies is not straightforward due to different anatomical indications for carotid artery stenting and endarterectomy. We consider that each technique has an essential role in carotid revascularisation. Good selection of patients, according to indications, contributes to satisfactory short- and long-term results.

Sections du résumé

BACKGROUND BACKGROUND
The revascularisation strategy for concomitant carotid and coronary disease is unknown. Simultaneous or stage coronary artery stenting and carotid endarterectomy are the most common revascularisation approach in the CABG population. This study aimed to evaluate long-term results after simultaneous carotid artery stenting or carotid endarterectomy in patients who underwent coronary artery bypass surgery.
METHODS METHODS
This is a prospective cohort non-randomised single-institution study. During the period from 2012 to 2015, sixty consecutive patients (65.9 ± 7.41 mean) underwent simultaneous carotid artery stenting and coronary artery bypass surgery (
RESULTS RESULTS
In-hospital mortality was insignificantly higher in the carotid endarterectomy, and coronary artery bypass surgery group (6.6% vs. 0%), the rate of stroke and myocardial infarction was similar (13.3% and 0% in the carotid endarterectomy and coronary artery bypass surgery group vs. 6.6% and 3.3% in the carotid artery stenting and coronary artery bypass surgery group, respectively). The intensive care unit readmission was significantly higher in the surgical revascularisation approach; it was an independent predictor of hospital mortality. The overall mortality during the follow-up period was 14.28% in both groups. Freedom of the composite adverse outcomes (stroke, myocardial infarction, and death) was 78.55%.
CONCLUSION CONCLUSIONS
Comparing two revascularisation strategies is not straightforward due to different anatomical indications for carotid artery stenting and endarterectomy. We consider that each technique has an essential role in carotid revascularisation. Good selection of patients, according to indications, contributes to satisfactory short- and long-term results.

Identifiants

pubmed: 36066027
doi: 10.1177/02184923221124881
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

977-984

Auteurs

Igor Zivkovic (I)

Department of Cardiac Surgery, 606093Dedinje Cardiovascular Institute, Belgrade, Serbia.

Stasa Krasic (S)

Cardiology Department, Mother and Child Health Institute of Serbia, Belgrade, Serbia.

Petar Milačić (P)

Department of Cardiac Surgery, 606093Dedinje Cardiovascular Institute, Belgrade, Serbia.

Petar Vukovic (P)

Department of Cardiac Surgery, 606093Dedinje Cardiovascular Institute, Belgrade, Serbia.

Miroslav Milicic (M)

Department of Cardiac Surgery, 606093Dedinje Cardiovascular Institute, Belgrade, Serbia.

Milos Jovanovic (M)

Department of Cardiac Surgery, 606093Dedinje Cardiovascular Institute, Belgrade, Serbia.

Zoran Tabakovic (Z)

Department of Cardiac Surgery, 606093Dedinje Cardiovascular Institute, Belgrade, Serbia.

Dragan Sagic (D)

Department of Interventional Radiology, 606093Dedinje Cardiovascular Institute, Belgrade, Serbia.

Nenad Ilijevski (N)

Department of Vascular Surgery, 606093Dedinje Cardiovascular Institute, Belgrade, Serbia.

Miodrag Peric (M)

Department of Cardiac Surgery, 606093Dedinje Cardiovascular Institute, Belgrade, Serbia.

Milovan Bojic (M)

Department of Cardiac Surgery, 606093Dedinje Cardiovascular Institute, Belgrade, Serbia.

Slobodan Micovic (S)

Department of Cardiac Surgery, 606093Dedinje Cardiovascular Institute, Belgrade, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH